Cargando…
Impact of Donepezil Supplementation on Alzheimer’s Disease-like Pathology and Gut Microbiome in APP/PS1 Mice
Based on published information, the occurrence and development of Alzheimer’s disease (AD) are potentially related to gut microbiota changes. Donepezil hydrochloride (DH), which enhances cholinergic activity by blocking acetylcholinesterase (AChE), is one of the first-line drugs for AD treatment app...
Autores principales: | Li, Yuan, Wu, Mengyao, Kong, Mengmeng, Sui, Shaomei, Wang, Qi, He, Yan, Gu, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537997/ https://www.ncbi.nlm.nih.gov/pubmed/37764150 http://dx.doi.org/10.3390/microorganisms11092306 |
Ejemplares similares
-
Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer’s disease-like pathology in APP/PS1 mice
por: Menden, Ariane, et al.
Publicado: (2022) -
Rapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil
por: Kim, Hye Yun, et al.
Publicado: (2016) -
Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
por: Feng, Min, et al.
Publicado: (2022) -
Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
por: Chacon-De-La-Rocha, Irene, et al.
Publicado: (2020) -
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)